Clinical trials industry is constantly evolving, and also new clinical studies are being launched at an ever-growing pace. Clinical trial services have widely regarded as the principal method for obtaining a reliable evaluation of treatment effect on patients. Conducting clinical trials is a growing trend in the medical industry for testing the safety level and effectiveness of a newly developed medical device or drug. They provide the reliable basis for evaluating the efficacy and safety of new treatments in clinical trials industry. The historical perspective, present status, and future strategy for clinical trials provide a contextual framework.
It is widely recognised that clinical trial success is dependent on patient recruitment
The pursuit for effective treatment modalities for cancer rides on sustained efforts with catalysed adoption of technological advancements that surpass traditional paradigms
Clinical trials are an integral part of drug development that decide the outcome of the newly developed or the newly formulated medicines
The complete human genome was published in March heralding a new era in pharmacogenomics advancing genome analysis and unlocking value additions in precision medicine
Recently a Drug Information Association American Statistical Associationsponsored Interdisciplinary Safety Evaluation working group published a recommended approach to the aggregate assessment of clinical trial safety data
Personalised medicine for cacner is a treatment module tailored to individual patients based on various factors including biomarkers Different types of biomarkers are measured from the tumour blood or urine using molecular biochemical physiological anatomical or imaging method before treatment or during the course of treatment
Traditional drug development can be timeconsuming and demands high investment Recent advances in medicine with the availability of certain powerful tools are enabling researchers to understand the inner workings of human disease at the molecular level therefore leading to increased demand and potential of discovering and developing innovative medic...
The finale of the th century brought fresh hopes of a revolution in medicine based on advancing knowledge of the human genome decoded The Human Genome Project was possible due to swift advances in genetic technologies that made possible the parallel testing of many Single Nucleotide Polymorphisms SNP in a cost effective manner
There are many advantages to studying a drugs performance under everyday conditions that cannot be matched in clinical trials which are essentially controlled experiments A traditional Randomised Controlled Trial RCT which has a specific design with established inclusion and exclusion criteria cannot anticipate all the realworld situations that can...
Healthcare today faces extraordinary challenges posed by the COVID pandemic along with a rise in chronic disease burden worldwide an aging population and the growth of the middleclass Asian population
